However, our results do not indicate that PEBP1 functioned as a kinase inhibitor in CRC, while it manipulated YAP1 phosphorylation by directly binding with PPP2R1A, a subunit of phosphatase PP2A. The gene discussed is YAP1; the disease is colorectal carcinoma.